Both in R&D — Physical & Biological Sciences
iSpecimen vs MaxCyte
Over the past year ISPC returned −97.5% and MXCT returned +10.3%; their daily moves had a correlation of 0.02.
ISPC −97.5% MXCT +10.3%Growth of $1, one year, split-adjusted
| Metric | ISPC | MXCT |
|---|---|---|
| Price | $0.8740 | $1.71 |
| Market cap | $2.2M | $176.5M |
| Today | +0.22% | +11.04% |
| 1 month | −28.9% | +44.9% |
| 6 months | −79.5% | +109.1% |
| Year to date | −91.6% | +10.3% |
| 1 year | −97.4% | +11.0% |
| Revenue growth (YoY) | −78.7% | −14.5% |
| Gross margin | 45.2% | 77.0% |
| Net margin | −896.9% | −122.0% |
| P/E (TTM) | — | — |
| Price / sales | 4.7× | 5.7× |
| Net cash | $4.4M | $105.7M |
| Dividend yield | — | — |
| Volatility (60d) | 90.1% | 78.8% |
| Short % of float | 10.4% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).